CAS 1035094-10-0|Iloprost-d4
Introduction：Basic information about CAS 1035094-10-0|Iloprost-d4, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Iloprost-d4 | ||
|---|---|---|---|
| CAS Number | 1035094-10-0 | Molecular Weight | / |
| Density | / | Boiling Point | / |
| Molecular Formula | C22H28D4O4 | Melting Point | / |
| MSDS | / | Flash Point | / |
Names
| Name | Iloprost-d4 (Major) |
|---|
Iloprost-d4 BiologicalActivity
| Description | Iloprost-d4 (Ciloprost-d4) is the deuterium labeled Iloprost. Iloprost (ZK 36374) is a synthetic analogue of prostacyclin PGI2[1][2]. |
|---|---|
| Related Catalog | Research Areas >>EndocrinologySignaling Pathways >>GPCR/G Protein >>Prostaglandin Receptor |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Della Bella S, et al. Novel mode of action of iloprost: in vitro down-regulation of endothelial cell adhesion molecules. Prostaglandins Other Lipid Mediat. 2001 Jun;65(2-3):73-83. [3]. van der Giessen WJ, et al. The effect of the stable prostacyclin analogue ZK 36374 on experimental coronary thrombosis in the pig. Thromb Res. 1984 Oct 1;36(1):45-51. [4]. Addonizio VP Jr, et al. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374). Surgery. 1987 Nov;102(5):796-807. |
Chemical & Physical Properties
| Molecular Formula | C22H28D4O4 |
|---|---|
| InChIKey | HIFJCPQKFCZDDL-GYJNXEMESA-N |
| SMILES | CC#CCC(C)C(O)C=CC1C(O)CC2CC(=CCCCC(=O)O)CC21 |
